WHO ICTRP trial
Improving delivery of secondary prophylaxis for rheumatic heart disease
ACTRN12613000223730 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12613000223730 |
|---|---|
| Public title | Improving delivery of secondary prophylaxis for rheumatic heart disease |
| Scientific title | Improving delivery of secondary prophylaxis for rheumatic heart disease: a stepped-wedge, community-randomised trial to increase proportion of clients receiving 80% or more of scheduled benzathine penicillin G injections. |
| Primary sponsor | University of Western Australia |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Rheumatic Heart Disease;Acute Rheumatic Fever; Rheumatic Heart Disease Acute Rheumatic Fever;Cardiovascular - Other cardiovascular diseases;Public Health - Health service research |
| Interventions | The intervention will involve the incorporation/modification of service delivery activities aligned with the chronic care model at the health centre level, specifically relating to care for clients with acute rheumatic fever (ARF) or… |
| Registration date | Feb 25, 2013 |
| Target size | 300 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: